Icon

ABSORICA (nda021951)- (10MG,20MG,25MG,30MG,35MG,40MG)

ISOTRETINOIN SUN PHARM INDS INC
10MG,20MG,25MG,30MG,35MG,40MG
Yes Yes
2021-Sep-21 Expired
None 2015-May-25
None No
ABSORICA is retinoids indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, ABSORICA is reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.
4 0 4
Total Other Developers 19
Drugs with Suitability No
10MG ** ** - - 2
20MG ** ** - - 2
25MG ** ** - - 1
30MG ** ** - 2 -
35MG ** ** - - -
40MG ** ** - 2 -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.